Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Futibatinib in Adenocarcinoma of Esophagus: NCT07594548 Clinical Landscape Report 2026
15 October 2026
NCT07594548 clinical landscape for Adenocarcinoma of Esophagus: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Fludarabine Phosphate in Pancreatic adenocarcinoma: NCT07594067 Clinical Landscape Report 2026
15 October 2026
NCT07594067 clinical landscape for Pancreatic adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Tegoprubart in Diabetes Mellitus, Type 1: NCT07592000 Clinical Landscape Report 2026
15 October 2026
NCT07592000 clinical landscape for Diabetes Mellitus, Type 1: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
68Ga-SNA014 in Pancreatic Cancer: NCT07597772 Clinical Landscape Report 2026
15 October 2026
NCT07597772 clinical landscape for Pancreatic Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Iparomlimab/Tuvonralimab in Locally Advanced Gastric Adenocarcinoma: NCT07595523 Clinical Landscape Report 2026
15 October 2026
NCT07595523 clinical landscape for Locally Advanced Gastric Adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development whi…
9 min read
Adebrelimab in Pancreatic Ductal Adenocarcinoma: NCT07595172 Clinical Landscape Report 2026
15 October 2026
NCT07595172 clinical landscape for Pancreatic Ductal Adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…
9 min read
Pemetrexed Dipotassium in Pancreatic adenocarcinoma metastatic: NCT07594626 Clinical Landscape Report 2026
15 October 2026
NCT07594626 clinical landscape for Pancreatic adenocarcinoma metastatic: endpoints, sponsor, phase, geography, readouts, asset context and development white…
9 min read
EVM14 in Squamous non-small cell lung cancer: NCT07614646 Clinical Landscape Report 2026
15 October 2026
NCT07614646 clinical landscape for Squamous non-small cell lung cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white s…
9 min read
[177Lu]Lu-DOTA-STR-17126 in Metastatic breast cancer: NCT07608848 Clinical Landscape Report 2026
15 October 2026
NCT07608848 clinical landscape for Metastatic breast cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Calcium carbonate/Vitamin D in Adenocarcinoma of prostate: NCT07598032 Clinical Landscape Report 2026
15 October 2026
NCT07598032 clinical landscape for Adenocarcinoma of prostate: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
![[68]Ga-OncoACP3 in Prostatic Cancer: NCT07600554 Clinical Landscape Report 2026](https://synapse-static.patsnap.com/strapi-static/Blog_cover_04_d2b0c3c766.jpg)
9 min read
[68]Ga-OncoACP3 in Prostatic Cancer: NCT07600554 Clinical Landscape Report 2026
15 October 2026
NCT07600554 clinical landscape for Prostatic Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Indomethacin in Prostatic Cancer: NCT07607990 Clinical Landscape Report 2026
15 October 2026
NCT07607990 clinical landscape for Prostatic Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.